20 /100
LOW RISK
Score updated May 30, 2026

PMCB — PharmaCyte Biotech, Inc. Dilution Risk Tracker

Track PMCB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PMCB — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.74 below $1 exchange minimum
🔔 Track PMCB — Get forecast alerts →

💹 Market Data

Market Cap$8.96M
Shares Outstanding10.74M
Float9.96M
Cash$20.54M
Debt$2.46M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 163.5% shares (2025Q4 vs prior)
28 institutional holders · 1.17M shares
#1 CITADEL ADVISORS LLC 415.8K shares
#2 HRT FINANCIAL LP 182.8K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 123.8K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest469.9K
Days to Cover1.2
% of Float4.7%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 31, 2025
xbrl XBRL CONVERTIBLE Apr 30, 2024
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track PMCB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PMCB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADT
🔬 More Research for PMCB
📊 PMCB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PMCB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.